Defeating lethal cancer: Interrupting the ecologic and evolutionary basis of death from malignancy

K Kenneth J. Pienta (Urology, Oncology, Pharmacology and Molecular Sciences, and Chemical and Biomolecular Engineering Cancer Ecology Center at the Brady Urological Institute Johns Hopkins University Baltimore Maryland USA) P Patrick L. Goodin (Philosophy, Howard University Washington District of Columbia USA) S Sarah R. Amend (Urology and Oncology Cancer Ecology Center at the Brady Urological Institute Johns Hopkins School of Medicine Baltimore Maryland USA)

Abstract

Abstract Despite the advances in cancer prevention, early detection, and treatments, all of which have led to improved cancer survival, globally, there is an increased incidence in cancer‐related deaths. Although each patient and each tumor is wholly unique, the tipping point to incurable disease is common across all patients: the dual capacity for cancers to metastasize and resist systemic treatment. The discovery of genetic mutations and epigenetic variation that emerges during cancer progression highlights that evolutionary and ecology principles can be used to understand how cancer evolves to a lethal phenotype. By applying such an eco‐evolutionary framework, the authors reinterpret our understanding of the metastatic process as one of an ecologic invasion and define the eco‐evolutionary paths of evolving therapy resistance. With this understanding, the authors draw from successful strategies optimized in evolutionary ecology to define strategic interventions with the goal of altering the evolutionary trajectory of lethal cancer. Ultimately, studying, understanding, and treating cancer using evolutionary ecology principles provides an opportunity to improve the lives of patients with cancer.

Article Details

Volume / Issue Vol. 75, Issue 3
Published June 01, 2025
Pages 183-202
ISSN 0007-9235
Publisher Wiley

Journal Info

CA: A Cancer Journal for Clinicians

Wiley

ISSN: 0007-9235 Open Access Q1 Medicine

Authors (3)

K

Kenneth J. Pienta

Urology, Oncology, Pharmacology and Molecular Sciences, and Chemical and Biomolecular Engineering Cancer Ecology Center at the Brady Urological Institute Johns Hopkins University Baltimore Maryland USA

P

Patrick L. Goodin

Philosophy, Howard University Washington District of Columbia USA

S

Sarah R. Amend

Urology and Oncology Cancer Ecology Center at the Brady Urological Institute Johns Hopkins School of Medicine Baltimore Maryland USA